ALLR: Allarity Therapeutics Inc
今日ALLR汇率已更改8.43%。当日,交易品种以低点0.85和高点0.95进行交易。
关注Allarity Therapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ALLR新闻
- Allarity Therapeutics在退伍军人事务部资助的肺癌stenoparib试验中完成首批患者给药
- First patients dosed in VA-funded stenoparib trial for lung cancer
- Allarity开始肺癌stenoparib联合疗法的二期临床试验
- Allarity begins phase 2 trial of stenoparib combination for lung cancer
- Stenoparib shows promising survival data in ovarian cancer patients
- Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
- Crude Oil Down 2%; US Durable Goods Orders Decline In July - Domo (NASDAQ:DOMO), Allarity Therapeutics (NASDAQ:ALLR)
- US Stocks Mixed; American Woodmark Posts Downbeat Sales - American Woodmark (NASDAQ:AMWD), Allarity Therapeutics (NASDAQ:ALLR)
- Allarity Therapeutics stock soars after FDA Fast Track designation
- FDA grants fast track designation for Allarity’s ovarian cancer drug
- Stock Market Today: S&P 500, Nasdaq Futures Decline— Palo Alto, XP, Allarity Earnings In Focus - Amcor (NYSE:AMCR), Allarity Therapeutics (NASDAQ:ALLR)
- Palo Alto Networks, Fabrinet And 3 Stocks To Watch Heading Into Monday - ATN International (NASDAQ:ATNI), Allarity Therapeutics (NASDAQ:ALLR)
- This MongoDB Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Accenture (NYSE:ACN), Allarity Therapeutics (NASDAQ:ALLR)
- Ascendiant Capital initiates Allarity Therapeutics stock with Buy rating
- Allarity Therapeutics appoints Jeff Ervin as new CFO
- Allarity Therapeutics receives patent acceptance in Australia for cancer diagnostic
- Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer
- Allarity Therapeutics appoints pharma veteran Høiland to board
- Allarity Therapeutics partners with IBRI on cancer drug research
- Allarity Therapeutics Announces First Patient Enrolled in New Phase 2 Clinical Trial Protocol of Stenoparib in Advanced Ovarian Cancer
- US Stocks Likely To Open Mixed After Disappointing Q1 Performance: 'April Does Better After A Weak Q1,' Says Expert - Allarity Therapeutics (NASDAQ:ALLR)
- XPeng, Ultralife And 3 Stocks To Watch Heading Into Tuesday - Ncino (NASDAQ:NCNO), Allarity Therapeutics (NASDAQ:ALLR)
常见问题解答
ALLR股票今天的价格是多少?
Allarity Therapeutics Inc股票今天的定价为0.90。它在0.85 - 0.95范围内交易,昨天的收盘价为0.83,交易量达到144。ALLR的实时价格图表显示了这些更新。
Allarity Therapeutics Inc股票是否支付股息?
Allarity Therapeutics Inc目前的价值为0.90。股息政策取决于公司,而投资者也会关注11.11%和USD。实时查看图表以跟踪ALLR走势。
如何购买ALLR股票?
您可以以0.90的当前价格购买Allarity Therapeutics Inc股票。订单通常设置在0.90或1.20附近,而144和5.88%显示市场活动。立即关注ALLR的实时图表更新。
如何投资ALLR股票?
投资Allarity Therapeutics Inc需要考虑年度范围0.62 - 2.35和当前价格0.90。许多人在以0.90或1.20下订单之前,会比较-10.00%和。实时查看ALLR价格图表,了解每日变化。
Allarity Therapeutics Inc股票的最高价格是多少?
在过去一年中,Allarity Therapeutics Inc的最高价格是2.35。在0.62 - 2.35内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Allarity Therapeutics Inc的绩效。
Allarity Therapeutics Inc股票的最低价格是多少?
Allarity Therapeutics Inc(ALLR)的最低价格为0.62。将其与当前的0.90和0.62 - 2.35进行比较,可以发现潜在的长期切入点。观看ALLR在图表上的实时走势以获取更多详细信息。
ALLR股票是什么时候拆分的?
Allarity Therapeutics Inc历史上曾经历过股票拆分。这些变化在公司行动后的、0.83和11.11%中可见。
- 前一天收盘价
- 0.83
- 开盘价
- 0.85
- 卖价
- 0.90
- 买价
- 1.20
- 最低价
- 0.85
- 最高价
- 0.95
- 交易量
- 144
- 日变化
- 8.43%
- 月变化
- -10.00%
- 6个月变化
- -41.56%
- 年变化
- 11.11%
- 实际值
- 预测值
- $-43.223 B
- 前值
- $-56.825 B
- 实际值
- 预测值
- $-94.837 B
- 前值
- $-85.541 B
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- $292.052 B
- 实际值
- 预测值
- 前值
- $348.877 B
- 实际值
- 预测值
- 0.1%
- 前值
- -0.1%
- 实际值
- 预测值
- 前值
- 0.2%
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 3.0
- 前值
- 12.6
- 实际值
- 预测值
- 5.0
- 前值
- 9.7
- 实际值
- 预测值
- 205 K
- 前值
- 227 K
- 实际值
- 预测值
- 1.841 M
- 前值
- 1.862 M
- 实际值
- 预测值
- -2.5%
- 前值
- 3.3%
- 实际值
- 预测值
- -0.2%
- 前值
- -0.3%
- 实际值
- 预测值
- 4.532 M
- 前值
- 8.530 M
- 实际值
- 预测值
- 0.120 M
- 前值
- 1.071 M
- 实际值
- 预测值
- 前值
- 2.650%